xanthenes has been researched along with Cardiomyopathy, Dilated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiesi, M; Depersin, H; Grüninger, S; Hasenfuss, G; Herzig, JW; Holubarsch, C; Kubalek, R; Leutert, T; Pieske, B; Pioch, K; Wenk, P | 1 |
| Fleck, E; Gräfe, M; Henning, B; Hildebrandt, AG; Kühne, S; Ott, T; Zünkler, BJ | 1 |
2 other study(ies) available for xanthenes and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2
Topics: Aniline Compounds; Azocines; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Electric Stimulation; Humans; In Vitro Techniques; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Quinolines; Stimulation, Chemical; Thiadiazines; Xanthenes | 1996 |
Effects of P2 purinoceptor agonists on membrane potential and intracellular Ca2+ of human cardiac endothelial cells.
Topics: Adenosine Triphosphate; Aniline Compounds; Animals; Calcium; Cardiomyopathy, Dilated; Cattle; Cells, Cultured; Coronary Vessels; Endothelium, Vascular; Humans; Membrane Potentials; Patch-Clamp Techniques; Pulmonary Artery; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Thionucleotides; Uridine Triphosphate; Xanthenes | 1999 |